US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Savaria Corp (S97) 銘柄情報

Savaria Corp (S97)

19.10

0.00

( 0.00% )

更新日時： 15:22:30

Savaria Corp (S97) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

19.10

( - )

買値

18.90

売値

19.20

出来高

0.00

0.00 日の範囲 0.00

12.10 52 週間の範囲 19.10

前日終値

19.10

始値

-

時刻

最終取引時間

-

平均取引量 (3 か月)

175

財務取引量

-

VWAP

-

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.1	6.11111111111	18	19.1	18	247	18.52496568	DE
4	0.9	4.94505494505	18.2	19.1	17.7	136	18.32061811	DE
12	1.4	7.90960451977	17.7	19.1	17.2	175	18.05003157	DE
26	4.3	29.0540540541	14.8	19.1	14.8	228	16.56684802	DE
52	6.8	55.2845528455	12.3	19.1	12.1	207	14.94863664	DE
156	4.7	32.6388888889	14.4	19.1	9.9	219	14.04357892	DE
260	4.7	32.6388888889	14.4	19.1	9.9	219	14.04357892	DE

S97 - Frequently Asked Questions (FAQ)

What is the current Savaria Corp share price?

The current share price of Savaria Corp is 19.10 €

What is the 1 year trading range for Savaria Corp share price?

Savaria Corp has traded in the range of 12.10 € to 19.10 € during the past year

north40000

north40000 3分前

Substitute 9% for $19 Billion. ATTR-CM is the heart condition treated with other stabilizers that failed in Phase 3 trial. Has Vascepa been in clinical trials for that condition?

tkg

A good 2:13m video in link...

https://x.com/SanCompounding/status/2074871489476878370

new-stocks

new-stocks 15分前

https://linktw.in/UQjike

new-stocks

new-stocks 15分前

https://linktw.in/UQjike

new-stocks

new-stocks 15分前

https://linktw.in/UQjike

new-stocks

new-stocks 16分前

https://linktw.in/UQjike

new-stocks

new-stocks 16分前

https://linktw.in/UQjike

new-stocks

new-stocks 16分前

https://linktw.in/UQjike

new-stocks

new-stocks 16分前

https://linktw.in/UQjike

new-stocks

new-stocks 17分前

https://linktw.in/UQjike

new-stocks

new-stocks 18分前

https://linktw.in/UQjike

new-stocks

new-stocks 19分前

https://linktw.in/UQjike

new-stocks

new-stocks 20分前

https://linktw.in/UQjike

new-stocks

new-stocks 20分前

https://linktw.in/UQjike

north40000

north40000 30分前

AZN major clinical trial failure/setback with gene-silencing Wainua drug partnered with IONS. AZN stock drops ~ $19 Billion. Bloomberg news is source.

DigitalLeviathan33

DigitalLeviathan33 1時間前

Good article! by ?????

DigitalLeviathan33

DigitalLeviathan33 1時間前

Good article! by [https://welove588.com/]?????[https://welove588.com/] insert-text-here

US Market News

US Market News 1時間前

Haier Europe Appoints Stagwell (STGW) as Creative Agency for the Haier Brand, Following Ingenuity+ Pitch ProcessJuly 9, 2026 3:35 AM
ACCESS NewswireLONDON, GB / ACCESS Newswire / July 9, 2026 /

sharkey1

sharkey1 1時間前

Eliquis is getting hard to find

https://www.medfinder.com/blog/why-is-eliquis-so-hard-to-find-explained-for-2026

price_and_volume

price_and_volume 2時間前

As mentioned: Expected news rarely moves stocks.

COB has been telegraphed for a year - promised & pumped & over-promoted.

Nobody cares - expected news is typically fully baked-in.

UNEXPECTED news has a fighting chance.

"Quitting CSE because

price_and_volume

price_and_volume 2時間前

I listened for about 5 minutes, lost interest.
Wow...seriously. Where is everybody that listened to the pitch tonight?
Not knocking the call specifically - honestly who cares? Promotion is boring. .

I'm patiently waiting for:

1. An attempt at fixing the s

Latin Resources

Twenty Mile Metals

SEG AL BAHIA PN

Fica Empreendimentos Imo... ON

Fundamental Global

Aledade Share Class Leve...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。